Zacks Research Analysts Increase Earnings Estimates for THC

Tenet Healthcare Co. (NYSE:THC - Free Report) - Zacks Research increased their Q2 2025 earnings estimates for shares of Tenet Healthcare in a report released on Tuesday, May 13th. Zacks Research analyst R. Department now expects that the company will post earnings of $2.75 per share for the quarter, up from their previous estimate of $2.68. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare's FY2025 earnings at $12.45 EPS, Q2 2026 earnings at $3.20 EPS, Q3 2026 earnings at $2.99 EPS, FY2026 earnings at $13.22 EPS and FY2027 earnings at $15.73 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, beating the consensus estimate of $3.11 by $1.25. The company had revenue of $5.22 billion during the quarter, compared to analysts' expectations of $5.15 billion. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The business's revenue for the quarter was down 2.5% compared to the same quarter last year. During the same period in the previous year, the company earned $3.22 EPS.

A number of other equities analysts have also recently issued reports on the stock. Truist Financial upped their price objective on shares of Tenet Healthcare from $175.00 to $190.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Cantor Fitzgerald reiterated an "overweight" rating and set a $177.00 price objective on shares of Tenet Healthcare in a research report on Thursday, February 13th. Robert W. Baird reiterated a "neutral" rating and set a $137.00 price objective (down from $153.00) on shares of Tenet Healthcare in a research report on Tuesday, April 15th. Baird R W cut shares of Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Finally, Morgan Stanley upped their price target on shares of Tenet Healthcare from $165.00 to $175.00 and gave the company an "overweight" rating in a research report on Monday, May 5th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Tenet Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $174.94.

Tenet Healthcare Price Performance

Shares of NYSE:THC traded up $1.52 during midday trading on Thursday, hitting $165.55. The stock had a trading volume of 1,767,306 shares, compared to its average volume of 1,550,635. The company's 50-day moving average price is $132.78 and its 200-day moving average price is $136.29. The company has a market capitalization of $15.38 billion, a P/E ratio of 5.14, a price-to-earnings-growth ratio of 1.02 and a beta of 1.63. Tenet Healthcare has a fifty-two week low of $109.82 and a fifty-two week high of $171.20. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25.

Institutional Trading of Tenet Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the company. US Bancorp DE raised its holdings in shares of Tenet Healthcare by 0.8% in the first quarter. US Bancorp DE now owns 8,620 shares of the company's stock valued at $1,159,000 after purchasing an additional 68 shares during the last quarter. Lindbrook Capital LLC boosted its position in shares of Tenet Healthcare by 5.3% in the first quarter. Lindbrook Capital LLC now owns 1,427 shares of the company's stock valued at $192,000 after acquiring an additional 72 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of Tenet Healthcare by 9.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 940 shares of the company's stock valued at $119,000 after acquiring an additional 80 shares during the period. Covestor Ltd boosted its position in shares of Tenet Healthcare by 10.4% in the first quarter. Covestor Ltd now owns 873 shares of the company's stock valued at $117,000 after acquiring an additional 82 shares during the period. Finally, GeoWealth Management LLC boosted its position in shares of Tenet Healthcare by 39.8% in the fourth quarter. GeoWealth Management LLC now owns 295 shares of the company's stock valued at $37,000 after acquiring an additional 84 shares during the period. Hedge funds and other institutional investors own 95.44% of the company's stock.

Insider Buying and Selling

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the firm's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the transaction, the director now directly owns 27,378 shares of the company's stock, valued at approximately $3,434,022.54. This trade represents a 25.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Paola M. Arbour sold 6,461 shares of the firm's stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $160.20, for a total transaction of $1,035,052.20. Following the completion of the transaction, the executive vice president now directly owns 27,848 shares in the company, valued at $4,461,249.60. This trade represents a 18.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,987 shares of company stock valued at $2,972,421 over the last ninety days. 0.81% of the stock is owned by corporate insiders.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.